PRQR
#3533
ProQR Therapeutics N.V. - Ordinary Shares
2.1 3 USD
-0.07%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-6.99%
Variación mensual
+23.12%
Variación en los últimos 6 meses
+38.31%
Cambio anual
-4.91%
Cierres anteriores
2.2 9
Open
2.1 3
Mínimo
2.1 3
Máximo
2.1 3
Volumen
19
Financials
- Market Capitalization 224.42 M
- Employee 187
- Founded 2012
- CEO Daniel A. de Boer
- Website www.proqr.com
- Headquarter Netherlands
- FIGI UNKNOWN
- Industry Biotecnología
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3523 |  TARA Protara Therapeutics, Inc. - Common Stock | 3.86 USD | +1.05% | 0.00% | -2.03% | +23.32% | 228.11 M USD | ||
| 3524 |  RNA Atrium Therapeutics, Inc. - Common Stock | 13.32 USD | -2.35% | -2.92% | +16.33% | -81.06% | 227.85 M USD | ||
| 3554 |  KROS Keros Therapeutics, Inc. - common stock | 11.08 USD | +0.45% | +2.31% | +9.06% | -26.62% | 219.69 M USD | ||
| 3556 |  GLSI Greenwich LifeSciences, Inc. - Common stock | 14.95 USD | -4.59% | -14.38% | +10.74% | +28.88% | 219.44 M USD |